Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Hopfner

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Frontiers in Neurology|April 28, 2022
Transcriptome and Proteome Analysis in LUHMES Cells Overexpressing Alpha-SynucleinMatthias Höllerhage, Markus Stepath, Michael Kohl, et al.
Heliyon|July 21, 2021
Atypical pantothenate kinase-associated neurodegeneration with variable phenotypes in an Egyptian familyAli S Shalash, Thomas W Rösler, Ibrahim Y Abdelrahman, et al.
Journal of Neurology|January 7, 2022
Innovative therapeutic concepts of progressive multifocal leukoencephalopathyNora Möhn, Lea Grote-Levi, Franziska Hopfner, et al.
Parkinsonism & Related Disorders|January 8, 2016
RAB39B mutations are a rare finding in Parkinson disease patientsTobias Löchte, Norbert Brüggemann, Eva-Juliane Vollstedt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 18, 2021
Allogeneic BK Virus-Specific T-Cell Treatment in 2 Patients With Progressive Multifocal LeukoencephalopathyFranziska Hopfner, Nora Möhn, Britta Eiz-Vesper, et al.
Neurology. Genetics|November 18, 2017
c.207C>G mutation in sepiapterin reductase causes autosomal dominant dopa-responsive dystoniaAli S Shalash, Thomas W Rösler, Stefanie H Müller, et al.
Journal of Neurology|August 29, 2024
Pharmacotherapy of motor symptoms in early and mid-stage Parkinson's disease: guideline "Parkinson's disease" of the German Society of NeurologyMatthias Höllerhage, Jos Becktepe, Joseph Classen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 8, 2013
No association between polymorphisms in the glutamate transporter SLC1A2 and Parkinson's diseaseSilke Appenzeller, Claudia Schulte, Sandra Thier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2013
The role of SCARB2 as susceptibility factor in Parkinson's diseaseFranziska Hopfner, Eva C Schulte, Brit Mollenhauer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 30, 2015
The impact of rare variants in FUS in essential tremorFranziska Hopfner, Giovanni Stevanin, Stefanie H Müller, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Frontiers in Neurology|April 28, 2022
Transcriptome and Proteome Analysis in LUHMES Cells Overexpressing Alpha-SynucleinMatthias Höllerhage, Markus Stepath, Michael Kohl, et al.
Heliyon|July 21, 2021
Atypical pantothenate kinase-associated neurodegeneration with variable phenotypes in an Egyptian familyAli S Shalash, Thomas W Rösler, Ibrahim Y Abdelrahman, et al.
Journal of Neurology|January 7, 2022
Innovative therapeutic concepts of progressive multifocal leukoencephalopathyNora Möhn, Lea Grote-Levi, Franziska Hopfner, et al.
Parkinsonism & Related Disorders|January 8, 2016
RAB39B mutations are a rare finding in Parkinson disease patientsTobias Löchte, Norbert Brüggemann, Eva-Juliane Vollstedt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 18, 2021
Allogeneic BK Virus-Specific T-Cell Treatment in 2 Patients With Progressive Multifocal LeukoencephalopathyFranziska Hopfner, Nora Möhn, Britta Eiz-Vesper, et al.
Neurology. Genetics|November 18, 2017
c.207C>G mutation in sepiapterin reductase causes autosomal dominant dopa-responsive dystoniaAli S Shalash, Thomas W Rösler, Stefanie H Müller, et al.
Journal of Neurology|August 29, 2024
Pharmacotherapy of motor symptoms in early and mid-stage Parkinson's disease: guideline "Parkinson's disease" of the German Society of NeurologyMatthias Höllerhage, Jos Becktepe, Joseph Classen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 8, 2013
No association between polymorphisms in the glutamate transporter SLC1A2 and Parkinson's diseaseSilke Appenzeller, Claudia Schulte, Sandra Thier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2013
The role of SCARB2 as susceptibility factor in Parkinson's diseaseFranziska Hopfner, Eva C Schulte, Brit Mollenhauer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 30, 2015
The impact of rare variants in FUS in essential tremorFranziska Hopfner, Giovanni Stevanin, Stefanie H Müller, et al.
Pageof 8